Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fotis Drakopanagiotakis

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The American Journal of the Medical Sciences|January 16, 2008
Organizing pneumoniaFotis Drakopanagiotakis, Vlasis Polychronopoulos, Marc A Judson
Cellular Signalling|November 7, 2019
Pirfenidone inhibits motility of NSCLC cells by interfering with the urokinase systemMatthias Krämer, Philipp Markart, Fotis Drakopanagiotakis, et al.
BMC Research Notes|November 28, 2012
Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patientsArgyris Tzouvelekis, Paschalis Ntolios, Andreas Karameris, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The American Journal of the Medical Sciences|January 16, 2008
Organizing pneumoniaFotis Drakopanagiotakis, Vlasis Polychronopoulos, Marc A Judson
Cellular Signalling|November 7, 2019
Pirfenidone inhibits motility of NSCLC cells by interfering with the urokinase systemMatthias Krämer, Philipp Markart, Fotis Drakopanagiotakis, et al.
BMC Research Notes|November 28, 2012
Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patientsArgyris Tzouvelekis, Paschalis Ntolios, Andreas Karameris, et al.
Pageof 1